Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells

被引：0
|
作者：
Kathryn Kline
Tim Luetkens
Rima Koka
Michael E. Kallen
Wengen Chen
Haroon Ahmad
Destiny Omili
Thierry Iraguha
Etse Gebru
Xiaoxuan Fan
Alexis Miller
Nishanthini Dishanthan
Jillian M. Baker
Kenneth A. Dietze
Kim G. Hankey
Jean A. Yared
Nancy M. Hardy
Aaron P. Rapoport
Saurabh Dahiya
Djordje Atanackovic
机构：
[1] University of Maryland Greenebaum Comprehensive Cancer Center,Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory
[2] University of Maryland School of Medicine,Department of Medicine
[3] University of Maryland,Department of Microbiology and Immunology
[4] University of Maryland School of Medicine,Department of Pathology
[5] University of Maryland School of Medicine,Diagnostic Radiology and Nuclear Medicine
[6] University of Maryland School of Medicine,Department of Neurology
[7] University of Maryland Greenebaum Comprehensive Cancer Center,Transplant and Cellular Therapy Program
[8] Stanford University,undefined
来源：
Cancer Immunology, Immunotherapy | / 73卷
关键词：
B cell lymphoma; CNS lymphoma; CAR-T cells; Neurotoxicity; T cells; Cytokines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Maude, Shannon L.
    Barrett, David M.
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Baniewicz, Diane
    White, Claire
    Talekar, Mala K.
    Shaw, Pamela A.
    Brogdon, Jennifer L.
    Young, Regina M.
    Scholler, John
    Marcucci, Katherine T.
    Levine, Bruce L.
    Frey, Noelle
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, J. Joseph
    June, Carl H.
    Grupp, Stephan A.
    BLOOD, 2016, 128 (22)
  • [22] CD19-targeted CAR T cells in refractory antisynthetase syndrome
    Mueller, Fabian
    Boeltz, Sebastian
    Knitza, Johannes
    Aigner, Michael
    Voelkl, Simon
    Kharboutli, Soraya
    Reimann, Hannah
    Taubmann, Jule
    Kretschmann, Sascha
    Roesler, Wolf
    Manger, Bernhard
    Wacker, Jochen
    Mougiakakos, Dimitrios
    Jabari, Samir
    Schroeder, Rolf
    Uder, Michael
    Roemer, Frank
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    LANCET, 2023, 401 (10379): : 815 - 818
  • [23] Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis
    Avouac, Jerome
    Cauvet, Anne
    Orvain, Cindy
    Boulch, Morgane
    Tilotta, Francoise
    Tu, Ly
    Thuillet, Raphael
    Ottaviani, Mina
    Guignabert, Christophe
    Bousso, Philippe
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (02) : 268 - 278
  • [24] Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Li, Yimei
    Leahy, Allison Barz
    Barrett, David M.
    Teachey, David T.
    Callahan, Colleen
    Fasano, Christina C.
    Rheingold, Susan R.
    DiNofia, Amanda
    Wray, Lisa
    Aplenc, Richard
    Baniewicz, Diane
    Liu, Hongyan
    Shaw, Pamela A.
    Pequignot, Edward
    Getz, Kelly D.
    Brogdon, Jennifer L.
    Fesnak, Andrew D.
    Siegel, Donald L.
    Davis, Megan M.
    Bartoszek, Chelsie
    Lacey, Simon F.
    Hexner, Elizabeth O.
    Chew, Anne
    Wertheim, Gerald B.
    Levine, Bruce L.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3044 - +
  • [25] Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
    Karschnia, Philipp
    Rejeski, Kai
    Winkelmann, Michael
    Schoeberl, Florian
    Buecklein, Veit L.
    Blumenberg, Viktoria
    Schmidt, Christian
    Blobner, Jens
    von Bergwelt-Baildon, Michael
    Tonn, Joerg-Christian
    Kunz, Wolfgang G.
    Subklewe, Marion
    von Baumgarten, Louisa
    NEUROLOGY, 2022, 98 (21) : 884 - 889
  • [26] Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (06) : 1347 - 1356
  • [27] Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
    Hill, Joshua A.
    Li, Daniel
    Hay, Kevin A.
    Green, Margaret L.
    Cherian, Sindhu
    Chen, Xueyan
    Riddell, Stanley R.
    Maloney, David G.
    Boeckh, Michael
    Turtle, Cameron J.
    BLOOD, 2018, 131 (01) : 121 - 130
  • [28] Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
    Bock, Tamara J.
    Colonne, Chanukya K.
    Fiorenza, Salvatore
    Turtle, Cameron J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025, : 241 - 261
  • [29] Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
    Mercadal, Santiago
    Ahn, Kwang Woo
    Allbee-Johnson, Mariam
    Ganguly, Siddhartha
    Geethakumari, Praveen Ramakrishnan
    Hong, Sanghee
    Malone, Adriana
    Murthy, Hemant
    Pawarode, Attaphol
    Sica, R. Alejandro
    Solh, Melhem
    Ustun, Celalettin
    Shadman, Mazyar
    Sauter, Craig S.
    Hamadani, Mehdi
    Herrera, Alex F.
    Lee, Catherine J.
    HAEMATOLOGICA, 2025, 110 (01) : 218 - 221
  • [30] Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies
    Ruella, Marco
    Barrett, David M.
    Kenderian, Saad S.
    Shestova, Olga
    Hofmann, Ted J.
    Scholler, John
    Lacey, Simon F.
    Melenhorst, J. Joseph
    Nazimuddin, Farzana
    Perazzelli, Jessica
    Christian, David A.
    Hunter, Christopher A.
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    Gill, Saar I.
    BLOOD, 2015, 126 (23)
12345